1. National Pharmacopoeia Committee. Pharmacopoeia of People’s Republic of China. Part 4. Beijing: Chemical Industry Press; 2015. p. 1213.
2. Tasly Pharmaceutical Group, the board of Directors of the Limited by Share Ltd. Tasly Pharmaceutical Group Limited by Share Ltd Announcement on the results of phase III clinical trial of Compound Danshen Dripping Pills in the United States FDA International Center. Tianjin 2016;12(24).
3. Shu Y, Li LD, Li YK. Investigation of status and quality of clinical on compound Salvia preparation for coronary heart disease. China Acad J Electron Publ House. 2008;24(6):76–9 (in Chinese).
4. Wang Y, Chu Y, Li W, et al. Advances in study on saponins in Panax notoginseng and their pharmacological activities. Chin Tradit Herb Drugs. 2015;46(9):1381–92 (in Chinese).
5. Peng L, Sun S, Xie LH, et al. Ginsenoside Re: pharmacological effects on cardiovascular system. Cardiovasc Ther. 2012;30(4):e183–8.